Use of intravenous immunoglobulin in critically ill patients.

about

CD1d- and MR1-Restricted T Cells in Sepsis Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin

P2860

Q26796132-5FA9BF2A-91DC-4687-A4F1-D9AEB3824C07 Q30400215-27FC20DD-17DB-4552-9D1F-3E26DA862A03

P2860

Use of intravenous immunoglobulin in critically ill patients.

Item

http://www.wikidata.org/entity/Q41667356

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Use of intravenous immunoglobulin in critically ill patients.

@en

type

Item

label

Use of intravenous immunoglobulin in critically ill patients.

@en

prefLabel

Use of intravenous immunoglobulin in critically ill patients.

@en

P1476

Use of intravenous immunoglobulin in critically ill patients.

@en

P2093

Gonzalo M L Bearman

http://www.w3.org/2001/XMLSchema#string

Summer Donovan

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice

The epidemiology of sepsis in the United States from 1979 through 2000

Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection.

Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1.

Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.

Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations

Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection.

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.

P304

447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11908-014-0447-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25388018

http://www.w3.org/2001/XMLSchema#string

Use of intravenous immunoglobulin in critically ill patients.

about

P2860

P2860

Use of intravenous immunoglobulin in critically ill patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698